A narrative review of cancer-related fatigue (CRF) and its possible pathogenesis
S Yang, S Chu, Y Gao, Q Ai, Y Liu, X Li, N Chen - Cells, 2019 - mdpi.com
Many cancer patients suffer from severe fatigue when treated with chemotherapy or
radiotherapy; however, the etiology and pathogenesis of this kind of fatigue remains …
radiotherapy; however, the etiology and pathogenesis of this kind of fatigue remains …
Cancer cachexia: Diagnosis, assessment, and treatment
M Sadeghi, M Keshavarz-Fathi, V Baracos… - Critical reviews in …, 2018 - Elsevier
Cancer cachexia is a multi-factorial syndrome, which negatively affects quality of life,
responsiveness to chemotherapy, and survival in advanced cancer patients. Our …
responsiveness to chemotherapy, and survival in advanced cancer patients. Our …
Diagnosis and outcomes of cachexia in Asia: working consensus report from the Asian Working Group for Cachexia
Chronic diseases often lead to metabolic disorders, causing anabolic resistance and
increased energy consumption, which result in cachexia. Cachexia, in turn, can lead to …
increased energy consumption, which result in cachexia. Cachexia, in turn, can lead to …
Cancer cachexia and skeletal muscle atrophy in clinical studies: what do we really know?
A Dolly, JF Dumas, S Servais - Journal of Cachexia …, 2020 - Wiley Online Library
Research investigators have shown a growing interest in investigating alterations underlying
skeletal muscle wasting in patients with cancer. However, skeletal muscle dysfunctions …
skeletal muscle wasting in patients with cancer. However, skeletal muscle dysfunctions …
Cachexia in cancer: what is in the definition?
G Vanhoutte, M van de Wiel… - BMJ open …, 2016 - bmjopengastro.bmj.com
Objective This study aimed to provide evidence-based results on differences in overall
survival (OS) rate to guide the diagnosis of cancer cachexia. Design Data collection and …
survival (OS) rate to guide the diagnosis of cancer cachexia. Design Data collection and …
Molecular pathways leading to loss of skeletal muscle mass in cancer cachexia–can findings from animal models be translated to humans?
TC Mueller, J Bachmann, O Prokopchuk, H Friess… - BMC cancer, 2016 - Springer
Background Cachexia is a multi-factorial, systemic syndrome that especially affects patients
with cancer of the gastrointestinal tract, and leads to reduced treatment response, survival …
with cancer of the gastrointestinal tract, and leads to reduced treatment response, survival …
Obesity, adipokines and cancer: an update
CH Lee, YC Woo, Y Wang, CY Yeung… - Clinical …, 2015 - Wiley Online Library
Obesity causes dysfunction of adipose tissue, with resultant chronic inflammation and
adverse interplay of various adipokines, sex steroids and endocrine hormones. All these …
adverse interplay of various adipokines, sex steroids and endocrine hormones. All these …
Cancer as a proinflammatory environment: metastasis and cachexia
N Inácio Pinto, J Carnier, LM Oyama… - Mediators of …, 2015 - Wiley Online Library
The development of the syndrome of cancer cachexia and that of metastasis are related with
a poor prognostic for cancer patients. They are considered multifactorial processes …
a poor prognostic for cancer patients. They are considered multifactorial processes …
[HTML][HTML] Effects of ruxolitinib treatment on metabolic and nutritional parameters in patients with myelofibrosis from COMFORT-I
Abstract Background In the COMFORT (COntrolled MyeloFibrosis Study with ORal JAK
Inhibitor Therapy)-I study, the Janus kinase (JAK) 1/JAK2 inhibitor ruxolitinib provided …
Inhibitor Therapy)-I study, the Janus kinase (JAK) 1/JAK2 inhibitor ruxolitinib provided …
Targeting inflammation in non-small cell lung cancer through drug repurposing
Lung cancer is the most common cause of cancer-related deaths. Lung cancers can be
classified as small-cell (SCLC) or non-small cell (NSCLC). About 84% of all lung cancers …
classified as small-cell (SCLC) or non-small cell (NSCLC). About 84% of all lung cancers …